Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF GRANTED OPTIONS (Details)

v3.24.1.1.u2
SCHEDULE OF GRANTED OPTIONS (Details) - £ / shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Number of shares options outstanding, Granted   0
Employees [Member]    
Number of shares options outstanding, beginning 5,328  
Weighted average exercise price outstanding, beginning £ 460  
Number of shares options outstanding, Granted  
Weighted average exercise price outstanding, Granted  
Number of shares options outstanding, Exercised  
Weighted average exercise price outstanding, Exercised  
Number of shares options outstanding, Cancelled  
Weighted average exercise price outstanding, Cancelled  
Number of shares options outstanding, ending 5,328  
Weighted average exercise price outstanding, ending £ 460  
Number of shares options exercisable, ending 5,328  
Weighted average exercise price exercisable, ending £ 460  
Number of shares options unexercisable, ending  
Weighted average exercise price unexercisable, ending  
Employees And Directors [Member]    
Number of shares options outstanding, beginning 37,066  
Weighted average exercise price outstanding, beginning £ 230  
Number of shares options outstanding, Granted 999,838  
Weighted average exercise price outstanding, Granted £ 1.07  
Number of shares options outstanding, Exercised (121,070)  
Weighted average exercise price outstanding, Exercised £ 0.0025  
Number of shares options outstanding, Cancelled (933)  
Weighted average exercise price outstanding, Cancelled £ 4,240  
Number of shares options outstanding, ending 914,901  
Weighted average exercise price outstanding, ending £ 6.01  
Number of shares options exercisable, ending 914,901  
Weighted average exercise price exercisable, ending £ 6.01  
Number of shares options unexercisable, ending  
Weighted average exercise price unexercisable, ending